Evidence map›Paper›PMID 36766443›Full record

ReviewDiagnostics (Basel, Switzerland)2023

Hysteroscopic Endometrial Ablation: From Indications to Instrumentation and Techniques-A Call to Action.

Salvatore Giovanni Vitale, Luigi Della Corte, Michał Ciebiera, Josè Carugno, Gaetano Riemma, Ricardo Bassil Lasmar, Bernardo Portugal Lasmar, Ilker Kahramanoglu, Bulent Urman, Mislav Mikuš and 3 more

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Salvatore Giovanni VitaleDivision of Gynecology and Obstetrics, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0001-6871-6097
Luigi Della CorteDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.ORCID 0000-0002-0584-2181
Michał CiebieraSecond Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, 00189 Warsaw, Poland.ORCID 0000-0001-5780-5983
Josè CarugnoMinimally Invasive Gynecology Unit, Obstetrics, Gynecology and Reproductive Sciences Department, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Gaetano RiemmaObstetrics and Gynecology Unit, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80128 Naples, Italy.ORCID 0000-0003-3676-7716
Ricardo Bassil LasmarDepartment of Surgery and Specialities, Federal Fluminense University, Rio de Janeiro 24020-140, Brazil.
Bernardo Portugal LasmarDepartment of Surgery and Specialities, Federal Fluminense University, Rio de Janeiro 24020-140, Brazil.
Ilker KahramanogluDepartment of Gynecologic Oncology, Emsey Hospital, 34912 Istanbul, Turkey.
Bulent UrmanDepartment of Obstetrics and Gynecology, Koc University School of Medicine, 34010 Istanbul, Turkey.
Mislav MikušDepartment of Obstetrics and Gynecology, University Hospital Centre Zagreb, Petrova 13, 10000 Zagreb, Croatia.ORCID 0000-0002-1365-8704
Carlo De AngelisDepartment of Maternal and Child Health and Urological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Péter TörökDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Stefano AngioniDivision of Gynecology and Obstetrics, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0002-2314-0028

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of minimally invasive techniques has led to the creation of innovative alternatives in cases where traditional methods are not applicable. In modern gynecology, hysteroscopy has become the gold standard for the evaluation and treatment of intrauterine pathology. Endometrial ablation (EA) is a procedure that uses different types of energy to destroy the endometrium and is currently used as an alternative technique in cases of heavy menstrual bleeding when medical treatment has failed and uterine preservation is desired. The aim of this review was to evaluate the feasibility, safety, and clinical outcomes of hysteroscopic EA as an alternative in patients with abnormal uterine bleeding. A detailed computerized search of the literature was performed in the main electronic databases (MEDLINE, EMBASE, Web of Science, PubMed, and Cochrane Library), from 1994 to June 2022, to evaluate the outcomes in patients with abnormal uterine bleeding (AUB) undergoing EA using hysteroscopic and non-hysteroscopic techniques. Only scientific publications in English were included. Twelve articles on the current use of endometrial ablation were included. Data on patient symptoms, tools used for EA, primary outcomes, and adverse events were recorded. EA should be considered an effective and safe approach in the management of patients with abnormal uterine bleeding caused by benign pathology, in whom medical treatment has failed or is contraindicated. Due to the lack of evidence, it would be interesting to determine whether EA would also have a role in the treatment of women with premalignant lesions, avoiding invasive surgical procedures or medical treatment in those patients for whom hysterectomy or the use of hormonal treatment is contraindicated.

Indexed as

ablationabnormal uterine bleedingendometrial ablationendometriumheavy menstrual bleedinghysterectomyhysteroscopymyomapolypresectoscope

Identifiers

PMID36766443
PMCPMC9914843

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.